SK Life Science Labs to Present New Preclinical Data on Targeted Protein Degradation at AACR Annual Meeting 2026

Key Facts Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline Programs featured: selective p300 and PRMT5 degraders p300 degrader data demonstrate: Deep anti-tumor activity in CBP mutant cancers (synthetic lethality) Broad efficacy...